Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-24 @ 7:57 PM
NCT ID:
NCT04360304
Eligibility Criteria:
Inclusion Criteria:
* Patient admitted in ICU and presenting an acute circulatory failure, defined by persistent hypotension (SAP \< 90mmHg or MAP \< 65mmHg) despite fluid resuscitation of 30ml/kg, or the need for vasopressor.
* Echocardiographic hemodynamic assessment for at least one of the following signs :
SAP \< 90mmHg; Urine output \< 0,5mL/kg/h during more than 2 hours; Blood lactate level \> 2mmol/L; Increase of Norepinephrine doses needed
* The patient or his trusted person / legal representative / member of the family gave his free and informed consent, et have signed the consent form, or patient included in an emergency situation.
* The patient has to benefit from the French national healthcare insurance.
* Age ≥ 18 years old.
Exclusion Criteria:
* Participation in another study, or exclusion period from another study assessing the same primary endpoint.
* Patient placed under judicial protection, or guardianship
* Patient or his trusted person refuses to sign consent form
* Pregnant, parturient, or breastfeeding woman
* Patient with poor echogenic window
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04360304
Study Brief:
Protocol Section:
NCT04360304